One of the most common misconceptions I hear is that trials are only for people who are seriously ill. In reality, healthy ...

Singapore scientists have unveiled an AI tool that predicts liver cancer relapse with 82% accuracy, turning pathology slides ...

Some women’s symptoms improved quickly after taking the pill, but depression persisted in others. Doctors are trying to learn ...

Bay Area, California company Loyal are testing their LOY-002 pill on nearly 1,300 senior dogs to see if a daily dosage is ...

Registered by the Federal Service for Supervision of Communications, Information Technology and Mass Communications.

For those seeking cataract surgery in Bozeman, Vance Thompson Vision offers a high level of surgical expertise supported by ...

IL-1 is considered one of the key mediators involved in the pathogenesis of OA, causing inflammation, joint pain, and ...

Takeda’s oral narcolepsy drug, oveporexton, has met the primary and secondary endpoints in two Phase III trials. The FirstLight (NCT06470828) and RadiantLight (NCT06505031) trials both met all their ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Sarepta Therapeutics has rejected a call by the Food and Drug Administration to stop shipments of its muscular dystrophy drug.

AI tool predicts liver cancer relapse with 82% accuracy, tackling a disease causing third-highest cancer-related deaths ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...